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Summary We report a rare case of tachycardia-induced cardiomyopathy with api-
cal stunning followed by partial aneurysmal formation. A 66-year-old male was
admitted because of dyspnea and palpitation. Electrocardiogram showed persis-
tent tachycardia due to atrial ﬂutter. Echocardiography and left ventriculography
showed severely diffuse hypokinesis with ejection fraction (EF) of 25%. Coronary
arteries were normal. Heart failure responded well to conventional medical treat-
ments. On day 9, persistent ST-segment elevation was disclosed before the ablation
for atrial ﬂutter. He was asymptomatic and free from the elevation of myocar-
dial enzymes in laboratory data. 201Tl scintigraphy showed slight hypoperfusion at
a narrow site of the apex, whereas 123I-methyl-iodophenyl-pentadecanoic acid
scintigraphy revealed complete defect in the apical area. Left ventriculography
showed akinesis at the localized site in the apex and mild hypokinesis in the basal
area, with EF of 43%. However, no abnormalities were detected in coronary arter-
ies during the ST-segment elevation. After 3 months, left ventriculography revealed
the aneurysmal formation at a part of the apex, with EF of 50%, although the apical
movement was improved. Moreover, coronary spasm was not induced by the intra-
coronary injection of ergonovine. In this case, a mechanism similar to Tako-Tsubo
cardiomyopathy was speculated for the apical stunning.
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achycardia-induced cardiomyopathy is commonly
een in the clinical setting [1—5]. It is character-
zed by the heart failure induced by persistent
achycardia such as atrial ﬁbrillation, atrial ﬂut-
er, or supraventricular tachycardia. As the systolic
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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dysfunction recovers promptly after the termina-
tion of tachycardia, it is considered as a reversible
myocardial disease. In the meanwhile, Tako-Tsubo
cardiomyopathy, which was ﬁrst reported by Satoh
et al. in Japan, is the myocardial disease with tran-
sient apical stunning which could not be explained
by epicardial coronary abnormalities. It was named
after its peculiar, yet characteristic, transient api-
cal systolic dysfunction. However, atypical forms
of Tako-Tsubo-like left ventricular ballooning occur-
ring in other regions such as basal or mid-ventricular
area have been reported [6—8].
We present a rare case of tachycardia-induced
cardiomyopathy accompanied by apical stunning
with sequential aneurysmal formation during the
recovery process, whose mechanism is considered
to be similar to that of Tako-Tsubo cardiomyopathy.
Case report
A 66-year-old male had been suffering from short-
ness of breath and palpitation on exertion for 6
months. He had no clinical history of diabetes
mellitus, hypertension, or dyslipidemia. Further-
more, he had no habit of smoking. He was
referred to our hospital because of palpitation
accompanied with nocturnal dyspnea. Electrocar-
Figure 1 Time course of electrocardiogram. ST-segment elev
the ablative therapy for atrial ﬂutter. The ST-segment elevatio
inverted in leads V3—V6 after 2 weeks. Note that the ampl
decreasing during the ST elevation.
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iogram (ECG) showed common type of atrial
utter with 2:1 atrio-ventricular conduction (heart
ate of 150 bpm) without ST-T segment abnormal-
ties (Figure 1). Chest radiograph showed mild
ardiomegaly (cardio-thoracic rate of 53%) with
ild bilateral pleural effusion and pulmonary
ongestion. Echocardiograghy revealed diffusely
evere hypokinesis of left ventricle (LV) with mild
ilatation [dimension of end-diastole/dimension of
nd-systole of 56/49mm, ejection fraction (EF) of
8%] (Table 1). No thrombus was detected in the
eft atrium including the left atrial appendage.
igniﬁcant regurgitant ﬂow was not observed by
olor doppler imaging. No major abnormalities
xcept for extremely high level of N′ terminal pro-
type natriuretic peptide value (10,002 pg/ml)
ere seen in the laboratory data. He was ini-
ially diagnosed with heart failure induced by the
achycardia. First of all, we attempted pharma-
ological cardioversion for the atrial ﬂutter after
he administration of heparin (3000 IU). Although
isopyramide (100mg) was injected intravenously,
o effects except for the slowdown of the heart
ate of 15 bpm were observed. Subsequent injec-ation in leads V3—V5 was disclosed on the 9th day before
n persisted for about a week. T waves were subsequently
itude of R waves in leads V4 and V5 was progressively
ion of verapamil (5mg) did not alter the heart
ate. Furosemide (10mg) was additionally injected
o eliminate pulmonary congestion. Oral admin-
stration of furosemide (20mg/day), verapamil
TIC with apical stunning 123
Table 1 Time course of clinical signs and echocardiographic parameters.
Day 1 Day 2 Day 5 Day 10 Day 19 3 months
Clinical signs
Heart rate (bpm) 145 68 72 70 68 72
Blood pressure (mmHg) 150/100 122/72 120/72 110/64 122/60 110/62
Echocardiographic parameters
IVST/PWT (mm) 11/9.5 — 11/9 12/10 10/9.5 10/9.5
Dd/Ds (mm) 56/49 — 53/43 52/42 51/39 51/37
kness
(
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rEjection fraction (%) 28 —
IVST, interventricular septal thickness; PWT, posterior wall thic
240mg/day), digoxin (0.25mg/day), and war-
arin (2mg/day) was immediately started. On the
ext day, cardiac catheterization was performed.
oronary angiography revealed normal coronary
Figure 2A). Left ventriculography showed diffusely
evere hypokinesis with EF of 25% (Figure 2B). Atrial
c
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igure 2 Coronary angiogram and left ventriculogram (Day
aphy revealed severely diffuse hypokinesis, with EF of 25% (B39 43 47 50
; Dd, dimension of end-diastole; Ds, dimension of end-systole.
urst pacing was subsequently conducted to termi-
ate atrial ﬂutter. The burst pacing with a pacing
ycle length of 170ms in the high right atrium
onverted the atrial ﬂutter to atrial ﬁbrillation
ollowed by restoration of sinus rhythm. Subjec-
ive symptoms were then completely relieved.
2). Coronary arteries were normal (A). Left ventriculog-
).
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Upp
y shFigure 3 Myocardial scintigrams (201Tl and 123I-BMIPP).
tion: imaging of vertical long axis. 123I-BMIPP scintigraph
scintigraphy.Chest radiograph showed the improvement of pul-
monary congestion on the next day. On the 5th day
after the admission, echocardiography revealed the
improvement of LV systolic function (EF of 39%)
(
T
a
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Figure 4 Left ventriculogram (during ST-segment elevation).
revealed akinesis of the apex (arrows), with EF of 43%. Bas
rather than hyperkinetic.er section: imaging of horizontal long axis. Lower sec-
owed more severe defect in the apical area than 201TlTable 1). Sinus rhythm was maintained afterward.
o prevent the recurrence of atrial ﬂutter, catheter
blation was performed on the 9th day. Surprisingly,
CG checked routinely before the operation showed
During the ST-segment elevation, left ventriculography
al area of the left ventricle showed mildly hypokinetic
TIC with apical stunning 125
F ont
a 0%.
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sigure 5 Left ventriculogram (after 3 months). After 3 m
t the anterior portion of the apex (arrows), with EF of 5
as improved.
T-segment elevation in leads V3—V5 (Figure 1).
he patient did not complain of chest discomfort
r any other symptom. No elevation of myocardial
nzyme level was seen in the laboratory data. More-
ver, neither pericardial effusion nor LV asynergy
as demonstrated by the portable echocardiogra-
hy, although the apical area could not be clearly
iewed. Therefore, we made a decision to follow
p prudently. As scheduled, bidirectional conduc-
ion block line in the cavo-tricuspid isthmus was
ompleted with no major complications. The level
f ST-segment was unchanged during the adminis-
ration of isoproterenol which was conducted to
emonstrate the complete bidirectional conduc-
ion block in the isthmus. However, on the next
ay after the ablation (10th day), echocardiogra-
hy was performed in detail as severer ST-segment
levation was observed in ECG. It demonstrated
evere hypokinesis in a part of the LV apical area
ith the improvement of global LV function (EF
f 43%) (Table 1). However, myocardial enzyme
evel (i.e. creatinine phosphokinase) was contin-
ously maintained within normal range after the
blation. Oral administration of carvedilol with an
nitial dosage of 2.5mg/day was started on the
0th day. As atrial ﬁbrillation with moderate ven-
ricular response occurred on the 10th day, oral
dministration of bepridil (200mg/day) was started
n the 11th day. The ST-segment elevation of over
mm continued for at least 4 days without any
vents (Figure 1). To further examine for the ST-
egment elevation, 201Tl myocardial scintigraphy
as conducted on the 11th day (2 days after the
blation) when ST-segment was maximally elevated
Figure 1). It revealed slight hypoperfusion at a
arrow site in the apical area, which might deny
o
n
a
t
mhs, left ventriculography revealed aneurysmal formation
The motion of the apex except for the aneurysmal area
he possibility of obstruction in coronary arteries
Figure 3). Cardiac catheterization was performed
gain to exclude coronary artery disease. Neither
tenosis nor delayed ﬂow was observed in coro-
ary arteries including branch vessels. However,
eft ventriculography showed akinesis of the apex
nd mild hypokinesis of the basal area, with EF of
3% (Figure 4). To further evaluate myocardial dam-
ge, 123I-methyl-iodophenyl-pentadecanoic acid
BMIPP) myocardial scintigraphy was conducted on
he 15th day. It revealed complete defect in the api-
al area (Figure 3). On the 15th day, ECG showed
ilder elevation in leads V3—V6 and low ampli-
ude of R waves in leads V4 and V5 (Figure 1). He
as discharged from hospital on the 20th day. Four
ays after the discharge, ECG showed inversion of
waves in leads V3—V6 (Figure 1). Three months
ater, inverted T waves remained and left ventricu-
ography revealed the aneurysmal formation at the
nterior portion of the apex with improved apical
ovement (EF 50%) (Figure 5). Furthermore, spasm
rovocation test by the intracoronary administra-
ion of ergonovine (right: 20g; left: 50g) was
egative.
iscussion
t is well-known that persistent tachycardia dete-
iorates LV systolic function because of marked
hortening of diastolic phase [1—5]. However, it is
ccasionally difﬁcult to make a differential diag-
osis from idiopathic dilated cardiomyopathy at
n initial visit [3]. This case was conﬁrmed as
achycardia-induced cardiomyopathy because of
ild LV dilatation with diffusely severe hypokinesis,
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concomitant tachycardia due to persistent atrial
ﬂutter with 2:1 atrio-ventricular conduction, nor-
mal coronary, and prompt recovery of the LV func-
tion. Additionally, myocarditis was unlikely because
he had no infectious sign prior to the admission.
During the recovery phase of tachycardia-
induced cardiomyopathy, ST-segment elevation
with apical stunning unexpectedly occurred, which
was disclosed by chance before the ablative
therapy. Perfusion scintigraphy performed while ST-
segment was maximally elevated showed a minor
abnormality at the apex, whereas scintigraphy asso-
ciated with fatty acid metabolism showed severe
defect in the apical area. This discrepancy sug-
gested that myocardial damage was not induced
by coronary ﬂow abnormalities. Regrettably, the
coronary angiography was not performed at the
superacute phase of ST-segment elevation as the
apical stunning could not be detected by the
portable echocardiography during the ablative ses-
sion. However, it was unlikely that severe ischemia
due to abnormalities of epicardial coronary arteries
including vasospasm might cause the apical stun-
ning in the present case because of four additional
reasons as follows: (1) No abnormalities including
delayed coronary ﬂow were detected by the coro-
nary angiography; (2) The patient was completely
asymptomatic during the ST-segment elevation; (3)
Myocardial enzyme level was continuously kept
within normal range despite the persistent ST-
segment elevation for over 4 days; (4) Coronary
spasm provocation test was negative.
In the present case, a mechanism of the
ST-segment elevation with the apical stunning
is unclear. However, this case reminds us of
Tako-Tsubo cardiomyopathy. Though a deﬁnite
mechanism of transient apical ballooning with Tako-
Tsubo cardiomyopathy remains unclear, several
investigators have speculated for it [9—15]. Cate-
cholamine toxicity and impaired microcirculation
which lead to myocardial stunning are considered
as dominant candidates of causes. In the present
case, the shape of LV at the end-systole was not typ-
ical ‘‘Tako-Tsubo’’ (ampulla) as the akinetic area
was quite limited at a part of the apex and the
motion of the basal area was mildly hypokinetic
rather than hyperkinetic. However, considering that
global cardiac function was not fully restored
from heart failure during the occurrence of apical
stunning, a mechanism similar to Tako-Tsubo car-
diomyopathy was likely to underlie this case. If so,
the ablative procedure including the isoproterenol
administration might possibly promote myocardial
damage. Judging from the long-lasting ST-segment
elevation and sequential ventricular aneurysmal
formation, myocardial stunning in the present case
[K. Ishibashi et al.
as considered to be severe. It was speculated
hat the incomplete recovery from tachycardia-
nduced myocardial damage contributed to the
evere and persistent myocardial stunning, which
ed to the partial aneurysmal formation. Although
e did not examine plasma concentrations of cat-
cholamine on the hospitalization, sympathetic
ervous system activity should be augmented dur-
ng the persistent tachycardia with heart failure.
owever, the question of why myocardial stun-
ing occurred during the recovery phase remains
nclear. To our speculation, the delayed apical
tunning was likely to be affected by the down-
egulation of -adrenoceptors in failed myocardium
ue to tachycardia.
In conclusion, the present case indicated that
pical stunning with ST-segment elevation could be
aused by non-ischemic myocardial damage during
he recovery phase of tachycardia-induced car-
iomyopathy.
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